Mm. Teixeira et al., Role of arachidonic acid in leukotriene B-4-induced guinea-pig eosinophil homotypic aggregation, EUR J PHARM, 384(2-3), 1999, pp. 183-190
The activation of eosinophils with the lipid mediator, leukotriene B-4, ind
uces their homotypic aggregation. Upon activation with leukotriene B-4, eos
inophils release a significant amount of arachidonic acid, a process depend
ent on the activation of phospholipase A(2). Here, we have evaluated whethe
r arachidonic acid could induce aggregation of eosinophils and whether the
release of arachidonic acid mediated the aggregation induced by leukotriene
B-4. The exogenous administration of arachidonic acid induced a concentrat
ion-dependent eosinophil homotypic aggregation. Pretreatment of eosinophils
with a 5-lipoxygenase inhibitor or a leukotriene B-4 receptor antagonist a
brogated arachidonic-acid-induced aggregation. Arachidonic acid induced a s
ignificant increase in leukotriene B-4 levels and desensitised leukotriene
B-4-induced aggregation in a dose-dependent manner. Moreover, this desensit
isation was effectively reversed by a 5-lipoxygenase inhibitor. However, ar
achidonic acid failed to induce a rise in intracellular Ca2+ in eosinophils
and failed to desensitise these cells to rises in intracellular Ca2+ induc
ed by leukotriene B-4. Pretreatment of eosinophils with the phospholipase A
(2) inhibitor, mepacrine, inhibited the aggregation responses induced by 1
nM leukotriene B-4 by approximately 50% but had no significant effect on th
e other concentrations of leukotriene B-4 tested (0.1 to 100 nM). In conclu
sion, arachidonic acid stimulates eosinophil aggregation indirectly via the
release of leukotriene B-4. Although a significant amount of arachidonic a
cid is released in response to activation of eosinophils with leukotriene B
-4, the arachidonic acid released does appear to play a major role in media
ting leukotriene B-4-induced eosinophil aggregation. (C) 1999 Elsevier Scie
nce B.V. All rights reserved.